Last edition
News about "next-generation peptide therapeutics"
Lupin Manufacturing Solutions (LMS), a subsidiary of Lupin, has entered into a long-term strategic partnership with PolyPeptide Group AG, a global contract development and manufacturing organisation specialising in peptide-based active pharmaceutical ingredients.
Next-generation Peptide Therapeutics | 12/12/2025 | By Darshana | 124
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members